Marin Jukic

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2023;49(1):e12867

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia

Milosavljevic F; Brusini I; Atanasov A; Manojlovic M; Vucic M; Orescanin-Dusic Z; Brkljacic J; Miljevic C; Nikolic-Kokic A; Blagojevic D; Wang C; Damberg P; Pesic V; Tyndale RF; Ingelman-Sundberg M; Jukic MM
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2023;16(1):62-72

Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits

Lenk HC; Lovsletten Smith R; O'Connell KS; Jukic MM; Kringen MK; Andreassen OA; Ingelman-Sundberg M; Molden E
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2022;15(9):2135-2145

Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population

Braten LS; Ingelman-Sundberg M; Jukic MM; Molden E; Kringen MK
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2022;42(4):396-399

Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching A Retrospective, Naturalistic Cohort Study Using Therapeutic Drug Monitoring Data From 640 Patients

Frederiksen T; Smith RL; Jukic MM; Molden E
Article: PSYCHIATRY RESEARCH. 2022;312:114535

CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability

Jokovic D; Milosavljevic F; Stojanovic Z; Supic G; Vojvodic D; Uzelac B; Jukic MM; Curcin AP
Article: CELLS. 2022;11(10):1597

Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids

Pridgeon CS; Bolhuis DP; Milosavljevic F; Manojlovic M; Vegvari A; Gaetani M; Jukic MM; Ingelman-Sundberg M
Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022;111(5):1165-1174

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients

Lenk HC; Kloditz K; Johansson I; Smith RL; Jukic M; Molden E; Ingelman-Sundberg M
Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021;110(3):750-758

Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates

Jukic MM; Smith RL; Molden E; Ingelman-Sundberg M
Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021;110(3):786-793

A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram

Braten LS; Haslemo T; Jukic MM; Ivanov M; Ingelman-Sundberg M; Molden E; Kringen MK
Article: PSYCHONEUROENDOCRINOLOGY. 2021;129:105234

Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy

Stanic D; Oved K; Israel-Elgali I; Jukic M; Batinic B; Puskas N; Shomron N; Gurwitz D; Pesic V
Article: SCHIZOPHRENIA RESEARCH. 2021;228:590-596

Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders

Smith RL; Tveito M; Kylleso L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
Article: FRONTIERS IN PHARMACOLOGY. 2021;12:650750

CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry

Molden E; Jukic MM
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;37:64-69

Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs - A study based on blood sample analyses from 24,239 patients

Smith RL; Tveito M; Kylleso L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
Article: NEUROPSYCHOPHARMACOLOGY. 2020;45(3):570-576

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients

Braten LS; Haslemo T; Jukic MM; Ingelman-Sundberg M; Molden E; Kringen MK
Article: FRONTIERS IN NEUROANATOMY. 2020;14:578900

Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats

Kapor S; Aksic M; Puskas L; Jukic M; Poleksic J; Milosavljevic F; Bjelica S; Filipovic B
Article: LANCET PSYCHIATRY. 2019;6(5):418-426

Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study

Jukic MM; Smith RL; Haslemo T; Molden E; Ingelman-Sundberg M
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2019;85(1):194-201

Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients

Haslemo T; Eliasson E; Jukic MM; Ingelman-Sundberg M; Molden E
Article: PSYCHIATRY RESEARCH. 2018;269:746-752

Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients

Miljevic CD; Nikolic-Kokic A; Blagojevic D; Milovanovic M; Munjiza A; Jukic MM; Pesic V; Lecic-Tosevski D; Spasic MB
Article: PHARMACOGENOMICS. 2018;19(12):931-936

Functional characterization of CYP2D7 gene variants

Jukic MM; Lauschke VM; Saito T; Hiratsuka M; Ingelman-Sundberg M
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(5):463-470

Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients

Jukic MM; Haslemo T; Molden E; Ingelman-Sundberg M
Article: JOURNAL OF NEUROSCIENCE. 2018;38(7):1662-1676

BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells.

Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
Article: MOLECULAR PSYCHIATRY. 2017;22(8):1155-1163

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

Jukic MM; Opel N; Stroem J; Carrillo-Roa T; Miksys S; Novalen M; Renblom A; Sim SC; Penas-Lledo EM; Courtet P; Llerena A; Baune BT; de Quervain DJ; Papassotiropoulos A; Tyndale RF; Binder EB; Dannlowski U; Ingelman-Sundberg M
Article: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2017;10:372

Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool

Zega K; Jovanovic VM; Vitic Z; Niedzielska M; Knaapi L; Jukic MM; Partanen J; Friedel RF; Lang R; Brodski C
Article: DRUG DEVELOPMENT RESEARCH. 2016;77(7):414-422

Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant

Pesic V; Petrovic J; Jukic MM
Article: NEUROSCIENCE. 2015;290:147-158

Deciphering the spatio-temporal expression and stress regulation of Fam107B, the paralog of the resilience-promoting protein DRR1 in the mouse brain.

Masana M; Jukic MM; Kretzschmar A; Wagner KV; Westerholz S; Schmidt MV; Rein T; Brodski C; Müller MB
Article: NEUROPSYCHOPHARMACOLOGY. 2015;40(4):839-848

Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder.

Jukic MM; Carrillo-Roa T; Bar M; Becker G; Jovanovic VM; Zega K; Binder EB; Brodski C
Article: PLOS ONE. 2015;10(10):e0139697

Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons.

Sherf O; Nashelsky Zolotov L; Liser K; Tilleman H; Jovanovic VM; Zega K; Jukic MM; Brodski C
Visa fler

Alla övriga publikationer

Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2022;43(12):1055-1069

Pharmacogenomics in treatment of depression and psychosis: an update

Jukic M; Milosavljevi F; Molden E; Ingelman-Sundberg M
Review: JAMA PSYCHIATRY. 2021;78(3):270-280

Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis

Milosavljevic F; Bukvic N; Pavlovic Z; Miljevic C; Pesic V; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM
Editorial comment: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;37:100-101

Can G_i1 biased 5-HT_2A inverse agonists improve the treatment of psychosis?

Jukic MM
Review: FRONTIERS IN PSYCHIATRY. 2020;11:94

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

van Westrenhen R; Aitchison KJ; Ingelman-Sundberg M; Jukic MM
Corrigendum: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2018;11:29

Dusp 16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool (vol 10, 372, 2017)

Zega K; Jovanovic VM; Vitic Z; Niedzielska M; Knaapi L; Jukic MM; Partanen J; Friedel RH; Lang R; Brodski C
Editorial comment: PHARMACOGENOMICS. 2014;15(15):1841-1844

Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates

Ingelman-Sundberg M; Persson A; Jukic MM

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI